233 related articles for article (PubMed ID: 18601742)
1. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
[TBL] [Abstract][Full Text] [Related]
2. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
[TBL] [Abstract][Full Text] [Related]
3. Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer.
Lemos MC; Coutinho E; Gomes L; Carrilho F; Rodrigues F; Regateiro FJ; Carvalheiro M
J Endocrinol Invest; 2008 Jun; 31(6):542-5. PubMed ID: 18591888
[TBL] [Abstract][Full Text] [Related]
4. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
Al-Dayel F; Al-Rasheed M; Ibrahim M; Bu R; Bavi P; Abubaker J; Al-Jomah N; Mohamed GH; Moorji A; Uddin S; Siraj AK; Al-Kuraya K
Leuk Lymphoma; 2008 Jan; 49(1):122-9. PubMed ID: 18203021
[TBL] [Abstract][Full Text] [Related]
6. Role of GST and NAT2 polymorphisms in thyroid cancer.
Hernández A; Xamena N; Surrallés J; Galofré P; Velázquez A; Creus A; Marcos R
J Endocrinol Invest; 2008 Nov; 31(11):1025-31. PubMed ID: 19169061
[TBL] [Abstract][Full Text] [Related]
7. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K
J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295
[TBL] [Abstract][Full Text] [Related]
8. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.
Gra O; Mityaeva O; Berdichevets I; Kozhekbaeva Z; Fesenko D; Kurbatova O; Goldenkova-Pavlova I; Nasedkina T
Genet Test Mol Biomarkers; 2010 Jun; 14(3):329-42. PubMed ID: 20373852
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population.
Kweon SS; Shin MH; Kim HN; Kim SH; Kang HC
Mol Biol Rep; 2014 Jun; 41(6):3793-9. PubMed ID: 24535271
[TBL] [Abstract][Full Text] [Related]
10. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
[TBL] [Abstract][Full Text] [Related]
11. Association of xenobiotic-metabolizing genes polymorphisms with cervical cancer risk in the Tunisian population.
Helaoui A; Sfar S; Boudhiba N; Dehghanian F; Dehbashi M; Bouchahda H; Hojati Z; Kenani A
Mol Biol Rep; 2023 Feb; 50(2):949-959. PubMed ID: 36376536
[TBL] [Abstract][Full Text] [Related]
12. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
Singh SA; Ghosh SK
Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
[TBL] [Abstract][Full Text] [Related]
14. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
[TBL] [Abstract][Full Text] [Related]
15. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
[TBL] [Abstract][Full Text] [Related]
16. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
[TBL] [Abstract][Full Text] [Related]
17. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
[TBL] [Abstract][Full Text] [Related]
18. Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.
Peddireddy V; Badabagni SP; Gundimeda SD; Mamidipudi V; Penagaluru PR; Mundluru HP
Eur J Med Res; 2016 Apr; 21():17. PubMed ID: 27090234
[TBL] [Abstract][Full Text] [Related]
19. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
Sreeja L; Syamala V; Hariharan S; Madhavan J; Devan SC; Ankathil R
J Hum Genet; 2005; 50(12):618-27. PubMed ID: 16228113
[TBL] [Abstract][Full Text] [Related]
20. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
